About

Publications While At HealthPartners

selected publications

Journal Article

Prognostic significance of ethnicity and age in advanced stage epithelial ovarian cancer: An NRG oncology/gynecologic oncology group study. 

Gynecologic Oncology. 2022

Secondary surgical cytoreduction for recurrent ovarian cancer. 

New England Journal of Medicine. 2019

A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study. 

Annals of Oncology. 2017

Contact

full name

M. F. Brady

Quick Info

 

Collaboration

Co-author network

Map of science